VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
OKYO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
OKYOOKYO Pharma Limited
$1.75$67M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksOKYOQuarterly Financials

OKYO Pharma Limited (OKYO) Quarterly Financials

120+ quarters historyFree accessUpdated daily

OKYO Pharma Limited (OKYO) quarterly income statement — complete revenue, gross profit & net income history

OKYO Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ2'26Q4'25Q2'25Q4'24Q2'24Q4'23Q2'23Q4'22Q2'22Q4'21Q2'21Q4'20Q2'20Q4'19Q2'19Q4'18Q2'18Q4'17Q2'17Q4'16
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold8851.29K1.27K3.37K4.13K3.94K2.41K1.88K81310.12K3.19K5.81K210675061590000
COGS % of Revenue--------------------
Gross Profit-885-1.29K-1.27K-3.37K-4.13K-3.94K-2.41K-1.88K-813-10.12K-3.19K-5.81K-210-67-506-1590000
Gross Margin %--------------------
Gross Profit Growth %30.53%61.75%69.19%14.51%-71.37%-109.69%-196.97%81.42%74.53%-74.05%-1418.47%-8529.31%58.48%57.73%------
Operating Expenses2.79M7.19M1.11K3.64K4.6K3.76K2.14K6.89M1732.66M1.11M425.14K1.1M1.38K1082959.63K48132156
OpEx % of Revenue--------------------
Selling, General & Admin2.84M4.14M791.71K04.11M02.95M5.26M2.28M2.52M1.07M257.73K746.97K0097935799164
SG&A % of Revenue--------------------
Research & Development-44.05K38.37K2.22M3.64K4.6K3.76K2.14K1.63M173139.72K37.04K167.41K348.34K1.08K812130000
R&D % of Revenue--------------------
Other Operating Expenses01000K-1000K000000000000012.45K000
Operating Income-2.79M-4.18M-3.01M-7.01K-8.73K-7.7K-4.55K-6.89M-985-2.67M-1.11M-431K-1.1M-1.15K-587-609-12.54K-57-132-172
Operating Margin %--------------------
Operating Income Growth %7.16%-59495.34%-34347.66%8.89%-91.74%99.89%-362.3%-158.34%99.91%-518.79%-1.3%-37287.04%-186408.63%-89.36%95.32%-964.9%-9411.88%66.7%37.31%61.02%
EBITDA-2.79M-4.18M-3.01M-7.01K-8.73K-7.7K-4.55K-6.89M-985-2.66M-1.11M-425.19K-1.1M0188-310-12.47K0-33883
EBITDA Margin %--------------------
EBITDA Growth %7.15%-59474%-34341.26%8.89%-91.76%99.89%-362.38%-159.33%99.91%-524.88%-1.03%--583126.85%100%101.51%--38060.9%-100%-103.87%-44.74%
D&A (Non-Cash Add-back)8852.56K1.27K22221110.12K3.19K5.81K2101.15K7752997357991.05K
EBIT-2.5M-7.08M-1.67K-7.01K-8.73K-7.7K-5.54K-6.94M-1.36K-2.83M-1.16M-516K-771-1.47K-775-404-95-57-132-253
Net Interest Income-84.58K-119.79K-758.38K-1.05K080010-62801800000000
Interest Income05.47K00080000001800000012
Interest Expense84.58K125.26K758.38K1.05K0000000000000000
Other Income/Expense206.69K307.6K-1.09M-1.05K-27.15K-97-990-49.31K-216-160K-55.44K-86.39K-26-166-12-60-166335
Pretax Income-2.59M-3.87M-4.1M-8.07K-8.73K-7.79K-5.54K-6.94M-1.2K-2.83M-1.17M-517K-812-1.64K-787-614-9.63K-58-50-228
Pretax Margin %--------------------
Income Tax52-1.85M-1.42M6083-120-1.18M68-25.85K86-76.93K-1-130-90-9.56K0490
Effective Tax Rate %-0%47.67%34.6%-0.74%-0.95%0.15%0%17.03%-5.66%0.91%-0.01%14.88%0.12%7.95%1.14%0%99.24%0%-98%0%
Net Income-2.59M-2.03M-2.68M-8.01K-8.82K-7.78K-4.55K-5.76M-918-2.8M-1.17M-440K-1.1M-1.28K-596-455-9.63K-47-50-155
Net Margin %--------------------
Net Income Growth %3.47%-25205.62%-30292.35%-2.89%-93.56%99.86%-396.38%-105.5%99.92%-536.59%-6.37%-34195.37%-183595.9%-181.91%93.81%-865.51%-19230.73%69.5%74.7%93.7%
Net Income (Continuing)-2.59M-2.03M-2.68M-8.13K-8.82K-7.78K-5.54K-5.76M-1.27K-2.8M-1.17M-440K-812-1.64K-787-614-12.54K-58-66-228
Discontinued Operations0000000000000000000108
Minority Interest00000000000000000000
EPS (Diluted)-0.07-0.04-0.08-0.00-0.00-0.00-0.00-0.36-0.00-0.27-0.11-0.05-0.13-0.00-0.00-0.00-0.000.000.000.00
EPS Growth %13.41%----99.89%--33.33%99.91%-500%15.38%---------
EPS (Basic)-0.07-0.04-0.08-0.00-0.00-0.00-0.00-0.36-0.00-0.27-0.11-0.05-0.13-0.00-0.00-0.00-0.000.000.000.00
Diluted Shares Outstanding37.42M39.49M33.57M32.97M25.71M22.87M21.64M16.12M14.01M10.55M10.14M9.78M8.54M8.06M8.06M5.92M5.86M5.86M5.86M5.86M
Basic Shares Outstanding37.42M39.49M33.57M32.97M25.71M22.87M21.64M16.12M14.01M10.55M10.15M9.78M8.54M8.06M8.05M5.92M5.86M5.86M5.86M5.42M
Dividend Payout Ratio--------------------